Funding round pulls in $1.5 million for Innovative Biosensors

03/20/2012 | MedCityNews.com

Innovative Biosensors has obtained $1.5 million of a targeted $2.7 million financing round. The Rockville, Md.-based company, which uses biosensors to create assays for rapid detection of cardiac and infectious diseases, is conducting clinical studies of the BioFlash-Dx system for use in spotting methicillin-resistant staphylococcus aureus.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY